Randomized clinical trial of nitazoxanide or sofosbuvir/daclatasvir for the prevention of SARS-CoV-2 infection.

Simiso Mandisa SokhelaBronwyn BoschAndrew HillBryony SimmonsJoana WoodsHilary JohnstoneGodspower AkpomiemieLeah EllisAndrew OwenCarmen Perez CasasWillem Daniel Francois Venter

Published in: The Journal of antimicrobial chemotherapy (2022)

In this randomized trial, nitazoxanide and sofosbuvir/daclatasvir had no significant preventative effect on infection with SARS-CoV-2 among healthcare workers and others at high risk of infection.

Keyphrases

hepatitis c virus
sars cov
hepatitis c virus infection
respiratory syndrome coronavirus
combination therapy
coronavirus disease